Press Releases

2008

November

11/10/2008
XOMA Reports Third Quarter 2008 Financial Results

11/10/2008
XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122

11/04/2008
XOMA to Announce Third Quarter 2008 Financial Results and Host Conference Call on November 10

11/04/2008
XOMA to Present at the Rodman and Renshaw Annual Global Investment Conference on November 11

October

10/28/2008
XOMA Appoints Steve Doberstein to Vice President of Research

10/25/2008
XOMA Presents Data On XOMA 052, An Anti-IL-1 Beta Antibody, in Rheumatoid Arthritis and Acute Gout Animal Models

10/23/2008
XOMA to Present At the BIO Investor Forum On October 30

10/22/2008
XOMA Enters Into $60 Million Committed Equity Financing Facility

September

09/22/2008
XOMA to Webcast Analyst and Investor Event 'Interleukin-1 Blockers: Unlocking Their Potential in Diabetes and Beyond' On September 25

09/16/2008
XOMA to Present At the UBS Global Life Sciences Conference On September 22

09/15/2008
New Programs Added in Antibody Collaboration Between XOMA and Takeda

09/10/2008
Texas A&M University System and XOMA Sign Memorandum of Understanding

09/09/2008
XOMA Awarded $65 Million Biodefense Contract by NIAID to Advance Drug Candidates Against Botulism Toxins Into Clinical Trials

09/08/2008
XOMA 052 Clinical Results Support New Type 2 Diabetes Therapeutic Approach of Targeting Inflammatory Damage to Insulin-Producing Cells

August

08/07/2008
XOMA Reports Second Quarter 2008 Financial Results

08/04/2008
XOMA to Announce Second Quarter 2008 Financial Results and Host Conference Call On Thursday, August 7

July

07/28/2008
XOMA Announces Departure of CFO

07/24/2008
XOMA Begins Phase 2a Clinical Trial to Evaluate XOMA 629 Topical Gel as a Treatment for the Common Skin Disease, Impetigo

07/15/2008
XOMA 052 Phase 1 Data to be Presented At European Association for the Study of Diabetes Annual Meeting

June

06/19/2008
XOMA to Present At the Jefferies Healthcare Conference On June 26

06/07/2008
XOMA 052 Demonstrates Anti-Inflammatory Effect in Arthritis Animal Studies; Data Presented At FOCIS

06/07/2008
XOMA 052 Demonstrates Anti-Inflammatory Effects in Diabetes Animal Studies; Data Presented At ADA

06/05/2008
XOMA to Present At the Needham Biotechnology and Medical Technology Conference On June 11

May

05/14/2008
XOMA to Present At the Rodman and Renshaw Global Healthcare Conference On May 20

05/12/2008
XOMA Refinances Royalty-Based Loan Facility for $55 Million

05/12/2008
XOMA Reports First Quarter 2008 Financial Results

05/05/2008
XOMA to Announce First Quarter 2008 Financial Results and Host Conference Call on Monday, May 12

April

04/01/2008
XOMA Announces New Audit Committee Member

March

03/12/2008
XOMA to Present At Cowen Health Care Conference On March 17

03/11/2008
XOMA Reports 2007 Results

03/10/2008
XOMA Appoints Mary L. Anderson as Vice President of Business Development

03/04/2008
XOMA to Announce 2007 Financial Results and Host Conference Call On Tuesday, March 11

February

02/27/2008
XOMA to Present At Susquehanna Financial Group Healthcare Conference On March 4

02/04/2008
XOMA to Present At BIO CEO and Investor Conference On February 11

January

01/18/2008
XOMA Appoints W. Denman Van Ness as Lead Independent Director

2007

December

12/06/2007
XOMA Speaks On Diabetes and Obesity Panel At RBC Capital Markets Healthcare Conference

November

11/26/2007
XOMA Announces Conference Call to Provide Overview of Business Strategy

11/15/2007
XOMA to Present At Lazard Capital Markets Healthcare Conference On November 27

11/08/2007
XOMA Reports Third Quarter 2007 Financial Results

11/01/2007
XOMA to Announce Third Quarter 2007 Financial Results and Host Conference Call On Thursday, November 8

October

10/30/2007
XOMA to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference